G

Genomed SA
WSE:GEN

Watchlist Manager
Genomed SA
WSE:GEN
Watchlist
Price: 24 PLN -16.08% Market Closed
Market Cap: 31.7m PLN

Wall Street
Price Targets

GEN Price Targets Summary
Genomed SA

There are no price targets for GEN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Genomed SA Competitors:
Price Targets
300142
Walvax Biotechnology Co Ltd
37% Downside
GBIO
Generation Bio Co
61% Upside
CMPX
Compass Therapeutics Inc.
143% Upside
300685
Amoy Diagnostics Co Ltd
43% Upside
2256
Abbisko Cayman Ltd
79% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
33% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
9% Upside
FDMT
4D Molecular Therapeutics Inc
324% Upside

Revenue
Forecast

Revenue Estimate
Genomed SA

Revenue forecast
is not available for
Genomed SA

Operating Income
Forecast

Operating Income Estimate
Genomed SA

Operating Income forecast
is not available for
Genomed SA

Net Income
Forecast

Net Income Estimate
Genomed SA

Net Income forecast
is not available for
Genomed SA
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GEN's stock price target?
Not Available

GEN doesn't have any price targets made by Wall Street professionals.

Back to Top